Integrity and cell-monolayer permeability of chitosan nanoparticles in simulated gastrointestinal fluids

Food Science and Biotechnology

Volumn 20, Issue 4, 2011, Pages 1033-1042

  Lee, Juyoung ^a   Ko, Sanghoon ^b   Kim, Hanbyul ^a   Kwon, Hoonjeong ^a  

^a Seoul National University   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Caco 2 cell monolayer; chitosan nanoparticle; in vitro digestion; particle integrity; surface charge

Indexed keywords

BIOLOGICAL ENVIRONMENTS; CACO-2 CELLS; CELL MONOLAYERS; CHITOSAN NANOPARTICLE; CHITOSAN NANOPARTICLES; CROSSLINKER; IN-VITRO; ISOELECTRIC POINT (PI); STRUCTURAL CHANGE;

CHARGED PARTICLES; CHITOSAN; FLUIDS; MONOLAYERS; NANOPARTICLES; PROTEINS;

CELLS;

EID: 80053954150     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-011-0141-3     Document Type: Article

References (39)

1. Desai KGH, Park HJ. Recent developments in microencapsulation of food ingredients. Dry. Technol. 23: 1361-1394 (2005).
2. Flanagan J, Singh H. Microemulsions: A potential delivery system for bioactives in food. Crit. Rev. Food Sci. 46: 221-237 (2006).
3. Müller G. Oral delivery of protein drugs: Driver for personalized medicine. Curr. Issues Mol. Biol. 13: 13-24 (2010).
4. Rieux A, Fievez V, Garinot M, Schneider YJ, Prat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J. Control. Release 116: 1-27 (2006).
5. Shahiwala A, Vyas TK, Amiji MM. Nanocarriers for systemic and mucosal vaccine delivery. Recent Pat. Drug Deliv. Formul. 1: 1-9 (2007).
6. Jia X, Chen X, Xu Y, Han X, Xu Z. Tracing transport of chitosan nanoparticles and molecules in Caco-2 cells by fluorescent labeling. Carbohyd. Polym. 78: 323-329 (2009).
7. Lin YH, Chung CK, Chen CT, Liang HF, Chen SC, Sung HW. Preparation of nanoparticles composed of chitosan/poly-γ-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6: 1104-1112 (2005).
8. Ma Z, Lim LY. Uptake of chitosan and associated insulin in Caco-2 cell monolayers: A comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res. 20: 1812-1819 (2003).
9. Sandri G, Bonferoni MC, Rossi S, Ferrari F, Gibin S, Zambito Y, Colo GD, Caramella C. Nanoparticles based on N-trimethylchitosan: Evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur. J. Pharm. Biopharm. 65: 68-77 (2007).
10. Yin L, Ding J, He C, Cui L, Tang C, Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 30: 5691-5700 (2009).
11. Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sung HW. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8: 146-152 (2007).
12. Ma Z, Lim TM, Lim LY. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int. J. Pharm. 293: 271-280 (2005).
13. Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, Hao JS, Cui FD. Bioadhesive polysaccharide in protein delivery system: Chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 249: 139-147 (2002).
14. Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res. 24: 2198-2206 (2007).
15. Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30: 2329-2339 (2009).
16. Hirano S, Seino H, Akiyama Y, Nonaka I. Chitosan: A bibocompatible material for oral and intravenous administrations. pp. 283-290. In: Progress in Biomedical Polymers. Gebelein CG, Dunn RL (eds). Plenum Press, New York, NY, USA (1990).
17. Jintapattanakit A, Junyaprasert VB, Mao S, Sitterberg J, Bakowsky U, Kissel T. Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int. J. Pharm. 342: 240-249 (2007).
18. Nimesh S, Thibault MM, Lavertu M, Buschmann MD. Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: Effect of pH and serum. Mol. Biotechnol. 46: 182-196 (2010).
19. Lynch I, Dawson KA. Protein-nanoparticle interactions. Nanotoday 3: 40-47 (2008).
20. Lynch I, Salvati A, Dawson KA. Protein-nanoparticle interactions: What does the cell see? Nat. Nanotechnol. 4: 546-547 (2009).
21. Huang M, Khor E, Lim LY. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm. Res. 21: 344-353 (2004).
22. Amiji MM, Qaqish RB. Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan-mucin interactions. Carbohyd. Polym. 38: 99-107 (1999).
23. Garrett DA, Failla ML, Sarama RJ. Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J. Agr. Food Chem. 47: 4301-4309 (1999).
24. Shim S, Kwon H. Assessing absorbability of bioactive components in aloe using in vitro digestion model with human intestinal cell. J. Food Biochem. 34: 425-438 (2010).
25. Bodmeier R, Chen H, Paeratakul O. A novel approach to the oral delivery of micro- or nanoparticles. Pharm. Res. 6: 413-417 (1989).
26. Huang M, Ma Z, Khor E, Lim LY. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm. Res. 19: 1488-1494 (2002).
27. Hong SS, Yoo HJ, Li H, Chung SJ, Kim DD, Shim CK. Effect of agitation on the in vitro permeability of xenobiotics across Caco-2 cell monolayers. J. Korean Pharm. Sci. 35: 111-116 (2005).
28. Lakeram M, Lockley DJ, Pendlington R, Forbes B. Optimisation of the Caco-2 permeability assay using experimental design methodology. Pharm. Res. 25: 1544-1551 (2008).
29. Guibal E, Milot C, Roussy J. Influence of hydrolysis mechanisms on molybdate sorption isotherms using chitosan. Separ. Sci. Technol. 35: 1021-1038 (2000).
30. Peng ZG, Hidajat K, Uddin MS. Adsorption of bovine serum albumin on nanosized magnetic particles. J. Colloid Interf. Sci. 271: 277-283 (2004).
31. Rezwan K, Studart A, Voros J, Gauckler L. Change of potential of biocompatible colloidal oxide particles upon adsorption of bovine serum albumin and lysozyme. J. Phys. Chem. B. 109: 14469-14474 (2005).
32. Vårum KM, Myhr MM, Hjerde RJN, Smidsrød O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohyd. Res. 299: 99-101 (1997).
33. Klockars M, Reitamo S. Tissue distribution of lysozyme in man. J. Histochem. Cytochem. 23: 932-940 (1975).
34. Mir MA. Lysozyme: A brief review. Postgrad. Med. J. 53: 257-259 (1977).
35. Peeters T, Vantrappen G. The paneth cell: A source of intestinal lysozyme. Gut 16: 553-558 (1975).
36. Ma Z, Yeoh HH, Lim LY. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J. Pharm. Sci. 91: 1396-1404 (2002).
37. Sadeghi AMM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani M, Junginger HE. Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur. J. Pharm. Biopharm. 70: 270-278 (2008).
38. Burton W, Nugent K, Slattery T, Summers B, Snyder L. Separation of proteins by reversed-phase high-performance liquid chromatography: I. Optimizing the column. J. Chromatogr. 443: 363-379 (1988).
39. Yoon JY, Kim JH, Kim WS. The relationship of interaction forces in the protein adsorption onto polymeric microspheres. Colloid. Surface A. 153: 413-419 (1999).